Home > Category > Signaling Pathways > Stem Cells & Wnt

Stem Cells & Wnt

31 related results
Display mode
All
All
ProductNum picture CAS No. Name and description Formula Quick order
CL3322
330829-30-6

MRT-10 (MRT 10)

98+%

C24H23N3O5S
CL3321
306387-90-6

KAAD-Cyclopamine (Synonyms: Cyclopamine-KAAD;3-Keto-N-aminoethyl-N’-aminocaproyldihydrocinnamoyl Cyclopamine)

98+%

C44H63N3O4
CL3073
2996821-30-6

LM-41

98+%

C19H14FNO2
CL2397
127243-85-0

H-89

98+%

C20 H20 Br N3 O2 S
CL2889
667463-62-9

BIO (GSK-3 Inhibitor IX | 6-bromoindirubin-3-oxime | 6-Bromoindirubin-3'-oxime | MLS 2052 | (2'Z,3'E)-6-Bromoindirubin-3'-oxime | 6-BIO | 6BIO

99+%

C16 H10BrN3O2
CL2888A
905854-03-7

(3S,4S)-Tivantinib | 3S,4S)-ARQ 197 | ARQ 198

98+%

C23H19N3O2
CL1006C
2109414-84-6

Laduviglusib dihydrochloride | CHIR-99021 dihydrochloride | CT99021 dihydrochloride

98+%

C22H18Cl2N8·2HCl
CL2733A
2109704-99-4

Belumosudil mesylate (KD025 mesylate; SLx-2119 mesylate)

98+%

C27H28N6O5S
CL2709
1422144-42-0

Netarsudil dimesylate ( AR-13324 dimesylate)

98+%

C30H35N3O9S2
CL2506
40391-99-9

Pamidronic Acid

98+%

C3H11NO7P2
CL2425
425386-60-3

Semagacestat | LY450139

98+%

C19H27N3O4
CLA1355
1447814-75-6

Brontictuzumab (Anti-NOTCH1)

95+%

CLA1337
1345009-45-1

Vantictumab (Anti-FZD)

95+%

CLA1334
1359940-55-8

Tarextumab (Anti-NOTCH3)

95+%

CLA1299
1243262-17-0

Demcizumab (Anti-DLL4)

95+%

CL2221
1226056-71-8

Thiazovivin

98+%

C15H13N5OS
CL2213
686770-61-6

N-(6-Methyl-2-benzothiazolyl)-2-[(3​,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2- d ]pyrim​idin-2-yl)thio]-acetamide; IWP-2

98+%

C22H18N4O2S3
CL1172
331752-47-7

Y27632 HCl hydrate | (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate | Y-27632 Dihydrochloride Monohydrate

98+%

C14H25Cl2N3O2
CL1621
865854-05-3

Tideglusib (Synonyms: NP031112; NP-12)

98+%

C19H14N2O2S
CL1037
879085-55-9

Vismodegib (GDC-0449)

98+%

C19H14Cl2N2O3S
1 2
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays